- Home
- WDH vs PACB Comparison
WDH vs PACB Comparison
Compare WDH & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- PACB
- Stock Information
- Founded
- WDH 2016
- PACB 2000
- Country
- WDH China
- PACB United States
- Employees
- WDH N/A
- PACB N/A
- Industry
- WDH Specialty Insurers
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- WDH Finance
- PACB Industrials
- Exchange
- WDH Nasdaq
- PACB Nasdaq
- Market Cap
- WDH 420.6M
- PACB 452.1M
- IPO Year
- WDH 2021
- PACB 2010
- Fundamental
- Price
- WDH $1.11
- PACB $1.97
- Analyst Decision
- WDH
- PACB Buy
- Analyst Count
- WDH 0
- PACB 15
- Target Price
- WDH N/A
- PACB $3.79
- AVG Volume (30 Days)
- WDH 226.3K
- PACB 9.3M
- Earning Date
- WDH 12-05-2024
- PACB 11-07-2024
- Dividend Yield
- WDH 4.14%
- PACB N/A
- EPS Growth
- WDH N/A
- PACB N/A
- EPS
- WDH 0.10
- PACB N/A
- Revenue
- WDH $375,221,621.00
- PACB $188,871,000.00
- Revenue This Year
- WDH N/A
- PACB N/A
- Revenue Next Year
- WDH $8.44
- PACB $27.48
- P/E Ratio
- WDH $12.27
- PACB N/A
- Revenue Growth
- WDH N/A
- PACB 29.24
- 52 Week Low
- WDH $0.94
- PACB $1.16
- 52 Week High
- WDH $1.53
- PACB $10.65
- Technical
- Relative Strength Index (RSI)
- WDH 52.84
- PACB 59.37
- Support Level
- WDH $0.97
- PACB $1.86
- Resistance Level
- WDH $1.20
- PACB $2.72
- Average True Range (ATR)
- WDH 0.06
- PACB 0.23
- MACD
- WDH -0.00
- PACB 0.04
- Stochastic Oscillator
- WDH 91.30
- PACB 62.14
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. It is a third-party insurance platform in China in terms of life and health insurance.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.